CCS
AKAO

Crosspoint Capital Strategies’s Achaogen Inc AKAO Stock Holding History

Crosspoint Capital Strategies’s Portfolio AKAO Stock Details AKAO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-328
Closed -$7K – 185
2017
Q2 		$7K Sell
328
-11
-3% -$251 0.01% 100
2017
Q1 		$9K Buy
+339
New +$6.96K 0.01% 72

Other funds holding AKAO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Crosspoint Capital Strategies's AKAO Position: Q3 2017 in Review

Crosspoint Capital Strategies sold out of Achaogen Inc (AKAO) in Q3 2017, closing a stake of 328 shares — an estimated $7K sold.

Crosspoint Capital Strategies first reported a position in AKAO in Q1 2017 and held it in 2 quarters. The position peaked at $9K in Q1 2017. 96 funds tracked by Wall St. Rank hold AKAO as of Q3 2017.

  • Crosspoint Capital Strategies reported no remaining Achaogen Inc position as of Q3 2017 after selling out during the quarter.
  • Crosspoint Capital Strategies sold 328 Achaogen Inc shares in Q3 2017, an estimated $7K.
  • Crosspoint Capital Strategies first reported a position in Achaogen Inc in Q1 2017 and held it in 2 quarters.
  • Crosspoint Capital Strategies's Achaogen Inc position peaked at $9K in Q1 2017.
  • 96 funds tracked by Wall St. Rank held Achaogen Inc as of Q3 2017.

Based on Crosspoint Capital Strategies's 13F filing for Q3 2017, filed 6 Nov 2017.